Impact of HAART exposure and associated lipodystrophy on advanced liver fibrosis in HIV/HCV-coinfected patients.
about
Sustained virological response and baseline predictors in HIV-HCV coinfected patients retreated with pegylated interferon and ribavirin after failing a previous interferon-based therapy: systematic review and meta-analysis.Transcriptomic assay of CD8+ T cells in treatment-naïve HIV, HCV-mono-infected and HIV/HCV-co-infected Chinese.Mitochondrial (dys)function - a factor underlying the variability of efavirenz-induced hepatotoxicity?Serum adiponectin in HIV-1 and hepatitis C virus mono- and co-infected Kenyan injection drug users.Cytokine Response Associated with Hepatitis C Virus Clearance in HIV Coinfected Patients Initiating Peg Interferon-α Based Therapy.Fibrosis progression in human immunodeficiency virus/hepatitis C virus coinfected adults: prospective analysis of 435 liver biopsy pairs.Use of first-generation HCV protease inhibitors in patients coinfected by HIV and HCV genotype 1.Endoplasmic reticulum stress in drug- and environmental toxicant-induced liver toxicity.Risk of liver decompensation with cumulative use of mitochondrial toxic nucleoside analogues in HIV/hepatitis C virus coinfection.A new 3p25 locus is associated with liver fibrosis progression in human immunodeficiency virus/hepatitis C virus-coinfected patients.Cannabis Use and Reduced Risk of Insulin Resistance in HIV-HCV Infected Patients: A Longitudinal Analysis (ANRS CO13 HEPAVIH).Factors associated with guideline-based hepatitis C virus (HCV) treatment initiation in HIV/HCV-coinfected patients: role of comorbidities and physicians' perceptions.Autophagy in drug-induced liver toxicity.Prevalence of anti-hepatitis C antibodies and its co-infection with HIV in rural Cameroon
P2860
Q34362476-88FABB8D-6069-4E22-8B81-E53A06429A35Q34428339-F0DDFC73-F143-4E39-BC22-690A6ABCBB38Q35223924-B50E55BB-F739-4B3E-939C-34BA25F9E8CCQ36051167-12B07EDC-8413-4D42-A1E2-6D57A20C6B1AQ36417572-82E8186E-2413-43CA-952D-23EBB4CBB398Q37619741-2EF6E352-BDC0-4A22-86C0-38E8744101ADQ38153794-18612532-76C1-48E7-93A8-0D901DBD7FE4Q38193602-48828F26-36B1-4092-9A53-95A55E3B400BQ40117183-EE00C9B4-6807-4B74-A495-9781D0DC1E1DQ40496274-D5010CA1-0A78-434C-8732-B4E96198C4DFQ41207222-AEFBE48D-24DA-4368-9450-20769A8F79E2Q42989781-021FEC58-2B84-422A-B4A2-390069830A6CQ47141835-0BDFD1EC-DB3B-4D2D-B9FE-CBC9B7D52C4DQ56917918-F82A107C-E4E2-4317-BF1E-7DB40C0EBCAA
P2860
Impact of HAART exposure and associated lipodystrophy on advanced liver fibrosis in HIV/HCV-coinfected patients.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Impact of HAART exposure and a ...... n HIV/HCV-coinfected patients.
@en
Impact of HAART exposure and a ...... n HIV/HCV-coinfected patients.
@nl
type
label
Impact of HAART exposure and a ...... n HIV/HCV-coinfected patients.
@en
Impact of HAART exposure and a ...... n HIV/HCV-coinfected patients.
@nl
prefLabel
Impact of HAART exposure and a ...... n HIV/HCV-coinfected patients.
@en
Impact of HAART exposure and a ...... n HIV/HCV-coinfected patients.
@nl
P2093
P2860
P1476
Impact of HAART exposure and a ...... n HIV/HCV-coinfected patients.
@en
P2093
ANRS CO 13 HEPAVIH Study Group
F Bani-Sadr
P2860
P304
P356
10.1111/J.1365-2893.2010.01417.X
P577
2011-01-11T00:00:00Z